| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 2.24e-07 | 20 | 54 | 4 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 2.64e-06 | 36 | 54 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 1.00e-05 | 50 | 54 | 4 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.27e-05 | 53 | 54 | 4 | GO:0016859 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 3.42e-05 | 68 | 54 | 4 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 3.62e-05 | 69 | 54 | 4 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 4.06e-05 | 71 | 54 | 4 | GO:0042054 | |
| GeneOntologyMolecularFunction | histone H3K36 trimethyltransferase activity | 7.14e-05 | 5 | 54 | 2 | GO:0140955 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 1.01e-04 | 172 | 54 | 5 | GO:0008757 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 1.73e-04 | 103 | 54 | 4 | GO:0008276 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 1.87e-04 | 105 | 54 | 4 | GO:0008170 | |
| GeneOntologyMolecularFunction | small GTPase binding | 2.22e-04 | 321 | 54 | 6 | GO:0031267 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 2.29e-04 | 44 | 54 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | methyltransferase activity | 2.72e-04 | 213 | 54 | 5 | GO:0008168 | |
| GeneOntologyMolecularFunction | transferase activity, transferring one-carbon groups | 3.44e-04 | 224 | 54 | 5 | GO:0016741 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 3.86e-04 | 127 | 54 | 4 | GO:0016616 | |
| GeneOntologyMolecularFunction | GTPase binding | 4.10e-04 | 360 | 54 | 6 | GO:0051020 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 5.28e-04 | 138 | 54 | 4 | GO:0016614 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 5.49e-04 | 13 | 54 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | GTP binding | 6.86e-04 | 397 | 54 | 6 | GO:0005525 | |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 9.41e-04 | 161 | 54 | 4 | GO:0051087 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 9.86e-04 | 766 | 54 | 8 | GO:0016491 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 1.15e-03 | 439 | 54 | 6 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 1.15e-03 | 439 | 54 | 6 | GO:0019001 | |
| GeneOntologyMolecularFunction | isomerase activity | 1.80e-03 | 192 | 54 | 4 | GO:0016853 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 3.38e-03 | 32 | 54 | 2 | GO:0004033 | |
| GeneOntologyMolecularFunction | ATPase activator activity | 3.38e-03 | 32 | 54 | 2 | GO:0001671 | |
| GeneOntologyMolecularFunction | histone modifying activity | 3.40e-03 | 229 | 54 | 4 | GO:0140993 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 3.40e-03 | 229 | 54 | 4 | GO:0003714 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 4.35e-03 | 398 | 54 | 5 | GO:0061659 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 4.50e-03 | 37 | 54 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 4.81e-03 | 126 | 54 | 3 | GO:0051082 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 4.85e-09 | 9 | 53 | 4 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 8.06e-09 | 10 | 53 | 4 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 2.73e-08 | 13 | 53 | 4 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 3.81e-08 | 14 | 53 | 4 | GO:1903299 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.83e-07 | 20 | 53 | 4 | GO:0006607 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 2.69e-06 | 38 | 53 | 4 | GO:0000413 | |
| GeneOntologyBiologicalProcess | protein folding | 3.04e-06 | 246 | 53 | 7 | GO:0006457 | |
| GeneOntologyBiologicalProcess | nuclear export | 7.77e-06 | 185 | 53 | 6 | GO:0051168 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 1.12e-05 | 54 | 53 | 4 | GO:0018208 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 3.32e-05 | 71 | 53 | 4 | GO:0006111 | |
| GeneOntologyBiologicalProcess | mRNA transport | 3.50e-05 | 145 | 53 | 5 | GO:0051028 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 4.16e-05 | 249 | 53 | 6 | GO:0015931 | |
| GeneOntologyBiologicalProcess | nuclear transport | 4.90e-05 | 378 | 53 | 7 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 4.90e-05 | 378 | 53 | 7 | GO:0006913 | |
| GeneOntologyBiologicalProcess | pericardium development | 5.01e-05 | 28 | 53 | 3 | GO:0060039 | |
| GeneOntologyBiologicalProcess | RNA transport | 8.57e-05 | 175 | 53 | 5 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 8.57e-05 | 175 | 53 | 5 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 9.28e-05 | 178 | 53 | 5 | GO:0051236 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 1.42e-04 | 195 | 53 | 5 | GO:0006606 | |
| GeneOntologyBiologicalProcess | import into nucleus | 1.64e-04 | 201 | 53 | 5 | GO:0051170 | |
| GeneOntologyBiologicalProcess | protein maturation | 1.69e-04 | 619 | 53 | 8 | GO:0051604 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | DNAJB1 ZNF469 NSD2 RBM10 PDX1 MAP3K10 MECOM NOSTRIN DNAJB5 COPS2 SMAD3 DNMT3B | 1.78e-04 | 1399 | 53 | 12 | GO:0045892 |
| GeneOntologyBiologicalProcess | gluconeogenesis | 1.90e-04 | 111 | 53 | 4 | GO:0006094 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | DNAJB1 ZNF469 NSD2 RBM10 PDX1 MAP3K10 MECOM NOSTRIN DNAJB5 COPS2 SMAD3 DNMT3B | 1.96e-04 | 1413 | 53 | 12 | GO:1902679 |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 2.17e-04 | 115 | 53 | 4 | GO:0019319 | |
| GeneOntologyBiologicalProcess | RNA localization | 2.34e-04 | 217 | 53 | 5 | GO:0006403 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 2.64e-04 | 121 | 53 | 4 | GO:0046364 | |
| GeneOntologyBiologicalProcess | methylation | 3.32e-04 | 234 | 53 | 5 | GO:0032259 | |
| GeneOntologyBiologicalProcess | transdifferentiation | 3.51e-04 | 11 | 53 | 2 | GO:0060290 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 3.68e-04 | 132 | 53 | 4 | GO:0043255 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 3.90e-04 | 134 | 53 | 4 | GO:0010906 | |
| GeneOntologyBiologicalProcess | glucose metabolic process | 4.02e-04 | 244 | 53 | 5 | GO:0006006 | |
| GeneOntologyBiologicalProcess | regulation of ribonucleoprotein complex localization | 4.96e-04 | 13 | 53 | 2 | GO:2000197 | |
| GeneOntologyBiologicalProcess | positive regulation of non-motile cilium assembly | 4.96e-04 | 13 | 53 | 2 | GO:1902857 | |
| GeneOntologyBiologicalProcess | intracellular protein transport | 5.61e-04 | 740 | 53 | 8 | GO:0006886 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex localization | 5.78e-04 | 14 | 53 | 2 | GO:0071166 | |
| GeneOntologyBiologicalProcess | hexose metabolic process | 7.99e-04 | 284 | 53 | 5 | GO:0019318 | |
| GeneOntologyBiologicalProcess | regulation of non-motile cilium assembly | 9.65e-04 | 18 | 53 | 2 | GO:1902855 | |
| GeneOntologyBiologicalProcess | monosaccharide metabolic process | 1.18e-03 | 310 | 53 | 5 | GO:0005996 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.76e-09 | 8 | 54 | 4 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 8.25e-09 | 10 | 54 | 4 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 3.90e-08 | 14 | 54 | 4 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.18e-07 | 18 | 54 | 4 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.87e-07 | 20 | 54 | 4 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 2.30e-07 | 21 | 54 | 4 | GO:0106068 | |
| GeneOntologyCellularComponent | inclusion body | 3.54e-06 | 90 | 54 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear pore | 1.35e-04 | 101 | 54 | 4 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear membrane | 2.04e-03 | 349 | 54 | 5 | GO:0031965 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 2.16e-07 | 16 | 48 | 4 | MP:0003701 | |
| MousePheno | abnormal morula morphology | 1.73e-06 | 26 | 48 | 4 | MP:0012058 | |
| MousePheno | decreased tumor latency | 3.14e-06 | 30 | 48 | 4 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 3.60e-06 | 31 | 48 | 4 | MP:0012129 | |
| MousePheno | abnormal tumor latency | 5.26e-06 | 34 | 48 | 4 | MP:0010307 | |
| MousePheno | abnormal blastocyst formation | 9.21e-06 | 39 | 48 | 4 | MP:0012128 | |
| MousePheno | aneuploidy | 5.53e-05 | 61 | 48 | 4 | MP:0004024 | |
| MousePheno | increased hepatocellular carcinoma incidence | 9.50e-05 | 70 | 48 | 4 | MP:0003331 | |
| MousePheno | increased incidence of tumors by chemical induction | 1.17e-04 | 141 | 48 | 5 | MP:0004499 | |
| MousePheno | increased lung carcinoma incidence | 1.45e-04 | 78 | 48 | 4 | MP:0008714 | |
| MousePheno | abnormal chromosome number | 2.11e-04 | 86 | 48 | 4 | MP:0004023 | |
| MousePheno | abnormal preimplantation embryo development | 2.89e-04 | 171 | 48 | 5 | MP:0009781 | |
| MousePheno | increased incidence of induced tumors | 3.05e-04 | 173 | 48 | 5 | MP:0002021 | |
| MousePheno | enlarged epididymis | 3.63e-04 | 99 | 48 | 4 | MP:0004931 | |
| MousePheno | increased sarcoma incidence | 4.06e-04 | 102 | 48 | 4 | MP:0002032 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 4.15e-04 | 286 | 48 | 6 | MP:0008873 | |
| MousePheno | increased lung tumor incidence | 4.87e-04 | 107 | 48 | 4 | MP:0008014 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 4.87e-04 | 107 | 48 | 4 | MP:0003694 | |
| MousePheno | increased respiratory system tumor incidence | 4.87e-04 | 107 | 48 | 4 | MP:0010298 | |
| MousePheno | increased carcinoma incidence | 5.53e-04 | 197 | 48 | 5 | MP:0002038 | |
| MousePheno | increased liver tumor incidence | 5.60e-04 | 111 | 48 | 4 | MP:0008019 | |
| MousePheno | increased hepatobiliary system tumor incidence | 5.60e-04 | 111 | 48 | 4 | MP:0010297 | |
| MousePheno | abnormal blastocyst hatching | 5.99e-04 | 113 | 48 | 4 | MP:0003693 | |
| MousePheno | abnormal rod electrophysiology | 7.28e-04 | 119 | 48 | 4 | MP:0004021 | |
| MousePheno | abnormal extraembryonic tissue morphology | SLC25A3 SETD2 ABCA1 AGO2 PLOD3 ARFRP1 ARID3A MECOM COPS2 DNMT3B | 8.66e-04 | 908 | 48 | 10 | MP:0002086 |
| MousePheno | abnormal chromosome morphology | 9.01e-04 | 126 | 48 | 4 | MP:0003702 | |
| MousePheno | abnormal mitosis | 9.56e-04 | 128 | 48 | 4 | MP:0004046 | |
| Domain | Ran_BP1 | 2.60e-08 | 12 | 52 | 4 | PF00638 | |
| Domain | RANBD1 | 2.60e-08 | 12 | 52 | 4 | PS50196 | |
| Domain | RanBD | 3.75e-08 | 13 | 52 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 3.75e-08 | 13 | 52 | 4 | IPR000156 | |
| Domain | GCC2_Rab_bind | 7.07e-07 | 7 | 52 | 3 | IPR032023 | |
| Domain | Rab_bind | 7.07e-07 | 7 | 52 | 3 | PF16704 | |
| Domain | - | 2.41e-06 | 10 | 52 | 3 | 1.10.220.60 | |
| Domain | Grip | 3.31e-06 | 11 | 52 | 3 | SM00755 | |
| Domain | GRIP | 3.31e-06 | 11 | 52 | 3 | PF01465 | |
| Domain | GRIP_dom | 4.40e-06 | 12 | 52 | 3 | IPR000237 | |
| Domain | GRIP | 4.40e-06 | 12 | 52 | 3 | PS50913 | |
| Domain | AWS | 7.56e-05 | 5 | 52 | 2 | SM00570 | |
| Domain | AWS | 7.56e-05 | 5 | 52 | 2 | PS51215 | |
| Domain | AWS_dom | 7.56e-05 | 5 | 52 | 2 | IPR006560 | |
| Domain | DnaJ_C | 2.70e-04 | 9 | 52 | 2 | IPR002939 | |
| Domain | DnaJ_C | 2.70e-04 | 9 | 52 | 2 | PF01556 | |
| Domain | HSP40/DnaJ_pept-bd | 2.70e-04 | 9 | 52 | 2 | IPR008971 | |
| Domain | - | 2.71e-04 | 207 | 52 | 5 | 1.25.40.10 | |
| Domain | TPR | 4.55e-04 | 129 | 52 | 4 | SM00028 | |
| Domain | TPR-like_helical_dom | 4.67e-04 | 233 | 52 | 5 | IPR011990 | |
| Domain | TPR_repeat | 5.11e-04 | 133 | 52 | 4 | IPR019734 | |
| Domain | TPR-contain_dom | 8.02e-04 | 150 | 52 | 4 | IPR013026 | |
| Domain | Post-SET_dom | 8.90e-04 | 16 | 52 | 2 | IPR003616 | |
| Domain | PostSET | 8.90e-04 | 16 | 52 | 2 | SM00508 | |
| Domain | - | 8.90e-04 | 16 | 52 | 2 | 3.20.20.100 | |
| Domain | POST_SET | 8.90e-04 | 16 | 52 | 2 | PS50868 | |
| Domain | NADP_OxRdtase_dom | 1.01e-03 | 17 | 52 | 2 | IPR023210 | |
| Domain | Aldo_ket_red | 1.01e-03 | 17 | 52 | 2 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 1.01e-03 | 17 | 52 | 2 | IPR001395 | |
| Domain | TPR_REGION | 1.14e-03 | 165 | 52 | 4 | PS50293 | |
| Domain | TPR | 1.14e-03 | 165 | 52 | 4 | PS50005 | |
| Domain | PWWP | 1.40e-03 | 20 | 52 | 2 | SM00293 | |
| Domain | zf-RanBP | 1.69e-03 | 22 | 52 | 2 | PF00641 | |
| Domain | PWWP | 1.85e-03 | 23 | 52 | 2 | PF00855 | |
| Domain | ZnF_RBZ | 1.85e-03 | 23 | 52 | 2 | SM00547 | |
| Domain | PWWP_dom | 1.85e-03 | 23 | 52 | 2 | IPR000313 | |
| Domain | ZF_RANBP2_2 | 1.85e-03 | 23 | 52 | 2 | PS50199 | |
| Domain | PWWP | 2.02e-03 | 24 | 52 | 2 | PS50812 | |
| Domain | ZF_RANBP2_1 | 2.02e-03 | 24 | 52 | 2 | PS01358 | |
| Domain | Znf_RanBP2 | 2.19e-03 | 25 | 52 | 2 | IPR001876 | |
| Domain | P-loop_NTPase | 2.23e-03 | 848 | 52 | 8 | IPR027417 | |
| Domain | DnaJ_domain_CS | 2.55e-03 | 27 | 52 | 2 | IPR018253 | |
| Domain | SET | 5.82e-03 | 41 | 52 | 2 | PF00856 | |
| Domain | ABC_transporter_CS | 6.10e-03 | 42 | 52 | 2 | IPR017871 | |
| Domain | SET | 7.28e-03 | 46 | 52 | 2 | SM00317 | |
| Domain | DnaJ | 7.90e-03 | 48 | 52 | 2 | PF00226 | |
| Domain | ABC_tran | 7.90e-03 | 48 | 52 | 2 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 7.90e-03 | 48 | 52 | 2 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 8.22e-03 | 49 | 52 | 2 | PS00211 | |
| Domain | DNAJ_1 | 8.22e-03 | 49 | 52 | 2 | PS00636 | |
| Domain | DNAJ_2 | 8.22e-03 | 49 | 52 | 2 | PS50076 | |
| Domain | DnaJ | 8.22e-03 | 49 | 52 | 2 | SM00271 | |
| Domain | - | 8.22e-03 | 49 | 52 | 2 | 1.10.287.110 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.43e-07 | 41 | 43 | 5 | MM15200 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 2.23e-07 | 18 | 43 | 4 | MM1549 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 3.59e-07 | 49 | 43 | 5 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 3.98e-07 | 50 | 43 | 5 | MM14610 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.68e-06 | 73 | 43 | 5 | MM14948 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 6.03e-06 | 86 | 43 | 5 | MM15413 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 6.33e-06 | 40 | 43 | 4 | MM14945 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 7.72e-06 | 42 | 43 | 4 | MM15039 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 8.40e-06 | 92 | 43 | 5 | MM14951 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 8.49e-06 | 43 | 43 | 4 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.22e-05 | 47 | 43 | 4 | MM14939 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.69e-05 | 51 | 43 | 4 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 2.29e-05 | 55 | 43 | 4 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.82e-05 | 58 | 43 | 4 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 2.82e-05 | 58 | 43 | 4 | MM14736 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 4.44e-05 | 65 | 43 | 4 | MM15147 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.10e-04 | 82 | 43 | 4 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.21e-04 | 84 | 43 | 4 | MM14929 | |
| Pathway | REACTOME_SUMOYLATION | 1.55e-04 | 169 | 43 | 5 | MM14919 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.80e-04 | 277 | 43 | 6 | MM15414 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 2.38e-04 | 100 | 43 | 4 | MM14561 | |
| Pathway | KEGG_LYSINE_DEGRADATION | 3.21e-04 | 44 | 43 | 3 | M13720 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 3.93e-04 | 114 | 43 | 4 | MM15361 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 4.33e-04 | 117 | 43 | 4 | MM15387 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 6.27e-04 | 129 | 43 | 4 | MM14894 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 8.74e-04 | 141 | 43 | 4 | MM15266 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 1.26e-03 | 70 | 43 | 3 | M27231 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 1.34e-03 | 271 | 43 | 5 | MM15388 | |
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 21205196 | ||
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 18949001 | ||
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 25187515 | ||
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 9037092 | ||
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 8603673 | ||
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 26632511 | ||
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 24403063 | ||
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 23818861 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.81e-10 | 7 | 54 | 4 | 11353387 | |
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 30944974 | ||
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 38838144 | ||
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 23536549 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.81e-10 | 7 | 54 | 4 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.81e-10 | 7 | 54 | 4 | 17372272 | |
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 38657106 | ||
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 12191015 | ||
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 22821000 | ||
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 20682751 | ||
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 3.62e-10 | 8 | 54 | 4 | 22262462 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 3.62e-10 | 8 | 54 | 4 | 21670213 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 3.62e-10 | 8 | 54 | 4 | 28745977 | |
| Pubmed | 3.62e-10 | 8 | 54 | 4 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 3.62e-10 | 8 | 54 | 4 | 21310149 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 6.50e-10 | 9 | 54 | 4 | 18394993 | |
| Pubmed | 6.50e-10 | 9 | 54 | 4 | 11553612 | ||
| Pubmed | 6.50e-10 | 9 | 54 | 4 | 10601307 | ||
| Pubmed | 6.50e-10 | 9 | 54 | 4 | 9733766 | ||
| Pubmed | 6.50e-10 | 9 | 54 | 4 | 28100513 | ||
| Pubmed | 6.50e-10 | 9 | 54 | 4 | 28877029 | ||
| Pubmed | 6.50e-10 | 9 | 54 | 4 | 17887960 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 1.08e-09 | 10 | 54 | 4 | 8857542 | |
| Pubmed | 1.08e-09 | 10 | 54 | 4 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 1.08e-09 | 10 | 54 | 4 | 16332688 | |
| Pubmed | 1.08e-09 | 10 | 54 | 4 | 21859863 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.70e-09 | 11 | 54 | 4 | 35771867 | |
| Pubmed | 1.70e-09 | 11 | 54 | 4 | 17069463 | ||
| Pubmed | 1.70e-09 | 11 | 54 | 4 | 34110283 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 3.67e-09 | 13 | 54 | 4 | 31427429 | |
| Pubmed | 6.99e-09 | 15 | 54 | 4 | 14697343 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | SLC25A3 RGPD4 DNAJB1 RGPD2 RANBP2 ARID3A RBM10 RGPD3 ZCCHC17 CPSF2 SMAD3 | 8.99e-09 | 701 | 54 | 11 | 30196744 |
| Pubmed | 3.72e-08 | 22 | 54 | 4 | 27717094 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.23e-07 | 7 | 54 | 3 | 15710750 | |
| Pubmed | 2.36e-07 | 86 | 54 | 5 | 37253089 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 3.68e-07 | 38 | 54 | 4 | 12791264 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 1.68e-06 | 370 | 54 | 7 | 22922362 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 10570961 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 25701119 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 28236635 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 15059886 | ||
| Pubmed | The miRISC component AGO2 has multiple binding sites for Nup358 SUMO-interacting motif. | 2.37e-06 | 2 | 54 | 2 | 33838501 | |
| Pubmed | The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3. | 2.37e-06 | 2 | 54 | 2 | 9665135 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 4.10e-06 | 153 | 54 | 5 | 26365490 | |
| Pubmed | ABC transporters as differentiation markers in glioblastoma cells. | 7.09e-06 | 3 | 54 | 2 | 25028266 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 19268428 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 21695170 | ||
| Pubmed | Rbm10 regulates inflammation development via alternative splicing of Dnmt3b. | 7.09e-06 | 3 | 54 | 2 | 29309623 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 27017521 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 30832689 | ||
| Pubmed | RGPD4 RGPD2 RANBP2 TRNT1 STXBP2 NSD2 STARD9 RGPD3 RAB39B NOSTRIN DNMT3B | 1.11e-05 | 1442 | 54 | 11 | 35575683 | |
| Pubmed | Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP. | 1.42e-05 | 4 | 54 | 2 | 15897867 | |
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 26822153 | ||
| Pubmed | 1.75e-05 | 99 | 54 | 4 | 27746211 | ||
| Pubmed | 2.36e-05 | 5 | 54 | 2 | 39390582 | ||
| Pubmed | TTBK2 circular RNA promotes glioma malignancy by regulating miR-217/HNF1β/Derlin-1 pathway. | 2.36e-05 | 5 | 54 | 2 | 28219405 | |
| Pubmed | Mixed lineage kinase 2 enhances trans-repression of Alien and nuclear receptors. | 2.36e-05 | 5 | 54 | 2 | 15062575 | |
| Pubmed | 2.36e-05 | 5 | 54 | 2 | 33135541 | ||
| Pubmed | Ablation of Dnmt3b in chondrocytes suppresses cell maturation during embryonic development. | 2.36e-05 | 5 | 54 | 2 | 29637597 | |
| Pubmed | 2.40e-05 | 1014 | 54 | 9 | 32416067 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 2.60e-05 | 1024 | 54 | 9 | 24711643 | |
| Pubmed | Histone H2A ubiquitination inhibits the enzymatic activity of H3 lysine 36 methyltransferases. | 3.54e-05 | 6 | 54 | 2 | 24019522 | |
| Pubmed | Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1. | 3.54e-05 | 6 | 54 | 2 | 15849193 | |
| Pubmed | The corepressor activity of Alien is controlled by CREB-binding protein/p300. | 4.94e-05 | 7 | 54 | 2 | 23441852 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 5.03e-05 | 626 | 54 | 7 | 33644029 | |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 5.91e-05 | 135 | 54 | 4 | 31077711 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 6.19e-05 | 647 | 54 | 7 | 26618866 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 6.34e-05 | 1149 | 54 | 9 | 35446349 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 7.35e-05 | 665 | 54 | 7 | 30457570 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 8.01e-05 | 146 | 54 | 4 | 23892456 | |
| Pubmed | 1.13e-04 | 963 | 54 | 8 | 28671696 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.56e-04 | 1294 | 54 | 9 | 30804502 | |
| Pubmed | Smad signaling pathways regulate pancreatic endocrine development. | 1.83e-04 | 13 | 54 | 2 | 23603491 | |
| Pubmed | 2.05e-04 | 549 | 54 | 6 | 38280479 | ||
| Pubmed | 2.13e-04 | 14 | 54 | 2 | 26912663 | ||
| Pubmed | 2.13e-04 | 14 | 54 | 2 | 15277382 | ||
| Pubmed | 2.19e-04 | 794 | 54 | 7 | 11076863 | ||
| Pubmed | Methylated DNMT1 and E2F1 are targeted for proteolysis by L3MBTL3 and CRL4DCAF5 ubiquitin ligase. | 2.45e-04 | 15 | 54 | 2 | 29691401 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 2.50e-04 | 1082 | 54 | 8 | 38697112 | |
| Pubmed | 2.77e-04 | 371 | 54 | 5 | 15747579 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 3.87e-04 | 1155 | 54 | 8 | 20360068 | |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 4.26e-04 | 226 | 54 | 4 | 37839992 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 4.42e-04 | 411 | 54 | 5 | 35182466 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 4.62e-04 | 231 | 54 | 4 | 16452087 | |
| Pubmed | 4.77e-04 | 418 | 54 | 5 | 34709266 | ||
| Pubmed | 4.88e-04 | 21 | 54 | 2 | 24923560 | ||
| Pubmed | 5.36e-04 | 22 | 54 | 2 | 11147971 | ||
| Pubmed | 5.42e-04 | 430 | 54 | 5 | 32581705 | ||
| Pubmed | The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities. | 5.86e-04 | 23 | 54 | 2 | 21231916 | |
| Pubmed | 6.42e-04 | 1247 | 54 | 8 | 27684187 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | 6.76e-04 | 1257 | 54 | 8 | 37317656 | |
| Pubmed | 6.81e-04 | 689 | 54 | 6 | 36543142 | ||
| Interaction | RGPD4 interactions | 2.78e-07 | 22 | 52 | 4 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 6.62e-07 | 27 | 52 | 4 | int:RGPD2 | |
| Interaction | RGPD3 interactions | 6.47e-06 | 47 | 52 | 4 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 7.66e-06 | 49 | 52 | 4 | int:RGPD1 | |
| Interaction | RGPD8 interactions | 3.97e-05 | 74 | 52 | 4 | int:RGPD8 | |
| Cytoband | 15q15.2 | 1.61e-04 | 16 | 54 | 2 | 15q15.2 | |
| Cytoband | 2q12.3 | 1.83e-04 | 17 | 54 | 2 | 2q12.3 | |
| Cytoband | 1p33 | 7.88e-04 | 35 | 54 | 2 | 1p33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p33 | 2.38e-03 | 61 | 54 | 2 | chr1p33 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.72e-05 | 34 | 40 | 3 | 487 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.19e-04 | 115 | 40 | 4 | 769 | |
| GeneFamily | Aldo-keto reductases | 4.92e-04 | 15 | 40 | 2 | 399 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 9.76e-04 | 21 | 40 | 2 | 89 | |
| GeneFamily | PWWP domain containing | 1.07e-03 | 22 | 40 | 2 | 1147 | |
| GeneFamily | Cytochrome P450 family 4 | 2.87e-03 | 36 | 40 | 2 | 1003 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 5.26e-03 | 49 | 40 | 2 | 584 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 6.30e-07 | 33 | 54 | 4 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 1.87e-06 | 43 | 54 | 4 | MM3857 | |
| Coexpression | GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP | 3.39e-06 | 199 | 54 | 6 | M7656 | |
| Coexpression | GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_DN | 5.74e-05 | 200 | 54 | 5 | M8958 | |
| Coexpression | GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_DN | 5.74e-05 | 200 | 54 | 5 | M7653 | |
| Coexpression | GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN | 5.74e-05 | 200 | 54 | 5 | M7162 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.76e-06 | 182 | 54 | 5 | 57f8b8d7b132f3ad6f2b1e79c3812fe938657d2c | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.49e-06 | 191 | 54 | 5 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.77e-06 | 194 | 54 | 5 | 45708cb2cafde10bf4e4798b81d47c3b1f6aaa14 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.87e-06 | 195 | 54 | 5 | 247803cf58c6d9c561a52aa34e581188ddad197e | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-MoAM-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.17e-06 | 198 | 54 | 5 | 1d92b09aeb03a95fa9e221813002045c4f41dd24 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.27e-06 | 199 | 54 | 5 | b827dd8a249f904a0ff930a6c4d3b00fb7bc6fb1 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.27e-06 | 199 | 54 | 5 | c0dcdda30485bb920d3706dcfb06f11b76b6ea37 | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 4.37e-06 | 200 | 54 | 5 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 151 | 54 | 4 | 3105b8c0c401faa92e1ab8223d435b21ed45c5b7 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.14e-05 | 159 | 54 | 4 | 6115cb03c2ad08e4c1b65893d522f685ff0bc692 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.24e-05 | 160 | 54 | 4 | a90eb621481fd07a821495db07d1032e109fd386 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.89e-05 | 166 | 54 | 4 | ce570b768988e30898cf0387c2aa99989631f13f | |
| ToppCell | facs-Heart-LV-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-05 | 170 | 54 | 4 | 4eaa22040e475100061475123aefa32b56481464 | |
| ToppCell | facs-Heart-LV-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-05 | 170 | 54 | 4 | 60041b2e57e958f300a5bc76851705c8baf297c2 | |
| ToppCell | facs-Heart-LV-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-05 | 170 | 54 | 4 | 793dde64f5517538b66de5f461a445c4ad6dd7b3 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.88e-05 | 174 | 54 | 4 | 09b091e24317c3f7bac043f04762a533e30793de | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.01e-05 | 175 | 54 | 4 | d3890bd0c570bb81434fdd1c5229891cefe2e462 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.42e-05 | 178 | 54 | 4 | 24e8c62060455159235985f456af0c5023a7f3f5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.42e-05 | 178 | 54 | 4 | 4f1cc954d4d9b5b2b75a4cf995ba81e2ada27084 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.42e-05 | 178 | 54 | 4 | 375156ba1c7b8592bf733c75f24968161f7cfa09 | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Dendritic|GI_large-bowel / Manually curated celltypes from each tissue | 6.70e-05 | 180 | 54 | 4 | 400f48aa2851d89bf3b60d721bc0f635f3ad86eb | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-05 | 180 | 54 | 4 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Dendritic-DC2|GI_large-bowel / Manually curated celltypes from each tissue | 6.70e-05 | 180 | 54 | 4 | d4ebe67a2735e244c08b238320bbb441ca88ee6f | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 183 | 54 | 4 | b0b835f3b1de1bd46a47e1b805aa8994cd3a4e3e | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.45e-05 | 185 | 54 | 4 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 187 | 54 | 4 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.93e-05 | 188 | 54 | 4 | cb091912f9b627a78a8793a37df7f1de839f887f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.43e-05 | 191 | 54 | 4 | 51f5af610983aa73b9f4ece6f27d281ebff89a04 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.43e-05 | 191 | 54 | 4 | 8fd6bdc9d2b1c8d364221d7bc68d03921b668ab5 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 8.60e-05 | 192 | 54 | 4 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 8.60e-05 | 192 | 54 | 4 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 8.78e-05 | 193 | 54 | 4 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | Control-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 8.95e-05 | 194 | 54 | 4 | c35bf04d5e7450cb6679a036fcabb1b28f409f29 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.95e-05 | 194 | 54 | 4 | 1dce6d4b6ac41f80677e3e4c335a4f383bd76f85 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.13e-05 | 195 | 54 | 4 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 9.13e-05 | 195 | 54 | 4 | 10fa47bdcf6c9784ea930b75a5861e139421feed | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-05 | 195 | 54 | 4 | 42bfdff88da1d07828c0ad65d412fb1752f0cee4 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 9.13e-05 | 195 | 54 | 4 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.13e-05 | 195 | 54 | 4 | 0ec1b572bbb92b6da3440139366a4c1743b1ad92 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.13e-05 | 195 | 54 | 4 | 028622b234551b185977fbee10c06851a45456a5 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 9.13e-05 | 195 | 54 | 4 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-05 | 195 | 54 | 4 | 34a9462f4e843f3065cc58c17ad71c1b5b836ae1 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.50e-05 | 197 | 54 | 4 | 66339b5aae3952f5c484c9dcb0cfb4fbd828d4cb | |
| ToppCell | Healthy_donor-cDC|Healthy_donor / disease group, cell group and cell class (v2) | 9.50e-05 | 197 | 54 | 4 | b57a27e5b855bbdd1dfa352540599d260dc482aa | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.50e-05 | 197 | 54 | 4 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | Healthy/Control-cDC|Healthy/Control / Disease group and Cell class | 9.50e-05 | 197 | 54 | 4 | 926423aae9fcf654f84b0f7621103a6a22d3aced | |
| ToppCell | mild_COVID-19-cDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 9.50e-05 | 197 | 54 | 4 | 44ebd3f967779bb7753fc6dcd9fde6d682f9ccd6 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.69e-05 | 198 | 54 | 4 | 579a22199643440b98e381147779ced630d4ed66 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 198 | 54 | 4 | c7dbf24caae5c4ef285845d13055de9e07281bb3 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 198 | 54 | 4 | 6a4161680b46b2c12353a693c403b5a4bb3da03f | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 198 | 54 | 4 | 0b41b3d6c2db795320e8b65d40d85fb8b618cc34 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.88e-05 | 199 | 54 | 4 | c4fc638a8dad3a9b77634e8912a9326c8a2f11f5 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.88e-05 | 199 | 54 | 4 | 9545ac59c8d75f5747dff86cb511a149dc103b31 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.88e-05 | 199 | 54 | 4 | 697a9a58c0cdb77222700d029873355d37f6ab28 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-04 | 200 | 54 | 4 | 6e50272d172b491200d9a255ed08e6d6998cfe02 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-04 | 200 | 54 | 4 | 840be665639a53ba9bafc19f7a81ca1e0436e329 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-04 | 135 | 54 | 3 | 88f86bab637f1ca1439c7de2d12be4329cf662b8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.51e-04 | 140 | 54 | 3 | 5e81fa3a19d23f0e9cae3878431ca1f78dff7238 | |
| ToppCell | primary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.65e-04 | 141 | 54 | 3 | 605d7b28e99c943f64b4095855a6f9f70e92cb09 | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.93e-04 | 143 | 54 | 3 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.65e-04 | 148 | 54 | 3 | 9fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.80e-04 | 149 | 54 | 3 | d9c47f523c75ddcd6131e45d2ffc24b970932cae | |
| ToppCell | (00)_Basal|World / shred by cell type and Timepoint | 7.80e-04 | 149 | 54 | 3 | 49e39206f37cee124ca4763c79425b805e50624b | |
| ToppCell | E16.5-samps-Myeloid-Fetal_macrophage-macrophage_-_intermediate_-_unactivated|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.95e-04 | 150 | 54 | 3 | 60fdd266aaca1b589b9a77465a4a7fad4921339a | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.11e-04 | 151 | 54 | 3 | a937e3e5a63bfeb37d2cabb3177760ec583dbf11 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.11e-04 | 151 | 54 | 3 | cba0939a6dd3519f6890695f5b237266ca1a7941 | |
| ToppCell | Severe-B_naive-5|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.42e-04 | 153 | 54 | 3 | 44572f87d403e314050ab935d2cd676c33d9c287 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.42e-04 | 153 | 54 | 3 | 7480522a47e367f8facc4f5d599fbaf0b5ad4007 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 8.74e-04 | 155 | 54 | 3 | 03fd443740272dcb547e39deaf7ae89b8307f241 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.74e-04 | 155 | 54 | 3 | fe6c4aba0e98cda84bf178aeac2e9fa834477f22 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.91e-04 | 156 | 54 | 3 | 53ded973358e3e48054130131e959f0d1f4ef60f | |
| ToppCell | facs-Aorta-Heart-18m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.91e-04 | 156 | 54 | 3 | 5b56217336771baf57d791efcb4e206c6aea83b1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.91e-04 | 156 | 54 | 3 | 4d2679e7639758c49fc25a2deb9109b08f0a3e57 | |
| ToppCell | Severe-B_naive-5|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.07e-04 | 157 | 54 | 3 | a57ee4a6febdff3ee3d1645836695e6e7c055cf8 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.58e-04 | 160 | 54 | 3 | 6005948e400e781cdb876ba350b3ec8991e3945f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.58e-04 | 160 | 54 | 3 | 529034a1101d7772d82f86beb5c6fa9c9dd97067 | |
| ToppCell | severe_influenza-cDC|World / disease group, cell group and cell class (v2) | 9.76e-04 | 161 | 54 | 3 | 802f8cafb5f499e3b2ec0193d6eb1ac9320b9287 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.93e-04 | 162 | 54 | 3 | 60d3fe1f5cec4285b8774ff078ebcc6bfaec26ed | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.93e-04 | 162 | 54 | 3 | 285e6d553f485fd9f1075c4e1b940da251b5ea35 | |
| ToppCell | E18.5-samps-Myeloid|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.93e-04 | 162 | 54 | 3 | 18e4a807e25f754a69e9eaaddfde40f8de9b8512 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.93e-04 | 162 | 54 | 3 | 0970e4eda60e3f015335e2726e6d565fb2f43372 | |
| ToppCell | Influenza_Severe-cDC|World / Disease group and Cell class | 1.03e-03 | 164 | 54 | 3 | c984228f73b9aa1aaf948541f64f41ed874770cd | |
| ToppCell | facs-BAT-Fat-18m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-03 | 164 | 54 | 3 | ab9c17f86b98e1a4d5db1bd3086edab1320ebda8 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-03 | 164 | 54 | 3 | 5621c2e3fae84d5a2e4f1595e454bcb3a2b3f93c | |
| ToppCell | E15.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.05e-03 | 165 | 54 | 3 | 8d3d5860a4785c4908160ae5fcb421ee80bd78ce | |
| ToppCell | E15.5-Endothelial-lymphatic_endothelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.05e-03 | 165 | 54 | 3 | 17ee6f269ed8d378465cf00ca59d48d8b106808e | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 1.08e-03 | 167 | 54 | 3 | 9062577a4b7902c9a888d706589d1b05221c0fa8 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Intermediate_macrophages|bone_marrow / Manually curated celltypes from each tissue | 1.10e-03 | 168 | 54 | 3 | 8ade4d098aeecda2d80c1cad1cebe9a063eae948 | |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-03 | 168 | 54 | 3 | 8ff4666fdda562913060b1cfa2dfab34e0606794 | |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-03 | 169 | 54 | 3 | 3296305dc4fa40c466dab56aab4eac302ae3d7f7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 1.14e-03 | 170 | 54 | 3 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.14e-03 | 170 | 54 | 3 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-03 | 170 | 54 | 3 | 8ea5ab8c890eb91c5b0aae3996e1d1c61c97f0c7 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l12-45|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-03 | 170 | 54 | 3 | e028e22ad051c2628248b212b5d28b891e0ee782 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-CLP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.18e-03 | 172 | 54 | 3 | 37ff83f53e99df62691d078ca6801b2c0ec2b123 | |
| ToppCell | MS-CD8-proli_CD4|MS / Condition, Cell_class and T cell subcluster | 1.18e-03 | 172 | 54 | 3 | 0b6dd257110b3f17fa71ab18a165b091a9d5ae9a | |
| ToppCell | Control-MAIT|Control / Disease group and Cell class | 1.18e-03 | 172 | 54 | 3 | 552bc62e8e8bb0ac1cd0452f4410a3af087787eb | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 1.18e-03 | 172 | 54 | 3 | 38d17e769fe8eac8b57b820490d4ddd969243ee7 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.20e-03 | 173 | 54 | 3 | 4efa0878ed1ede8fa5d6c191a76d4f70558ba761 | |
| ToppCell | facs-Heart-LA-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-03 | 174 | 54 | 3 | 30c083fe4711735e83dccfd00fcd746ae673d353 | |
| Disease | autosomal dominant limb-girdle muscular dystrophy type 1 (implicated_via_orthology) | 1.62e-05 | 4 | 49 | 2 | DOID:0110305 (implicated_via_orthology) | |
| Disease | congenital myopathy 21 (implicated_via_orthology) | 1.62e-05 | 4 | 49 | 2 | DOID:0081353 (implicated_via_orthology) | |
| Disease | 10-undecenoate 11:1n1 measurement | 5.64e-05 | 7 | 49 | 2 | EFO_0021099 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 7.51e-05 | 49 | 49 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | BMI-adjusted waist-hip ratio, asthma | 1.21e-04 | 10 | 49 | 2 | EFO_0007788, MONDO_0004979 | |
| Disease | alpha-hydroxybutyric acid measurement | 1.76e-04 | 12 | 49 | 2 | EFO_0010458 | |
| Disease | keratoconus | 1.83e-04 | 66 | 49 | 3 | MONDO_0015486 | |
| Disease | intraocular pressure measurement | 1.91e-04 | 509 | 49 | 6 | EFO_0004695 | |
| Disease | skin melanoma (is_marker_for) | 2.08e-04 | 13 | 49 | 2 | DOID:8923 (is_marker_for) | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 3.62e-04 | 17 | 49 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | Myeloid Leukemia | 4.06e-04 | 18 | 49 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 4.06e-04 | 18 | 49 | 2 | C0023466 | |
| Disease | gastric ulcer | 5.56e-04 | 21 | 49 | 2 | EFO_0009454 | |
| Disease | Antiglaucoma preparations and miotics use measurement | 8.56e-04 | 26 | 49 | 2 | EFO_0009944 | |
| Disease | spine bone mineral density | 1.03e-03 | 119 | 49 | 3 | EFO_0007701 | |
| Disease | colorectal cancer (is_implicated_in) | 1.08e-03 | 121 | 49 | 3 | DOID:9256 (is_implicated_in) | |
| Disease | basophil count | 1.21e-03 | 483 | 49 | 5 | EFO_0005090 | |
| Disease | peptic ulcer disease | 1.38e-03 | 33 | 49 | 2 | MONDO_0004247 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 1.57e-03 | 301 | 49 | 4 | DOID:684 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLGWKGIVKESGVKH | 86 | Q719I0 | |
| VGRGLVTLDGSKWKK | 121 | Q8N1L4 | |
| LHIVIKRGWKEGTKI | 211 | O75953 | |
| KVLELEGEKGEWGFK | 56 | P61201 | |
| GGTIWKIVKDGEEEI | 156 | Q9P2I0 | |
| KEFGIGDLVWGKIKG | 221 | Q9UBC3 | |
| VELGWGKVLLVKDNG | 86 | Q96NN9 | |
| GKVSKAAWIRKIKGL | 1016 | Q5XX13 | |
| VGKVGEWAIRKLGLV | 2021 | O95477 | |
| VRIWKVEKGPDGKAI | 41 | Q13112 | |
| EEKTWKGSIGLLLGK | 821 | Q8IY63 | |
| RGIAGEKFDIVKKWG | 86 | P53365 | |
| DKILTIEVKKGWKEG | 201 | P25685 | |
| GEGKDRIFKVSIKWV | 121 | Q9UKV8 | |
| VGQWKERGIGDIKIL | 2346 | P49792 | |
| WKEGSGLGRKKQGIV | 871 | P98175 | |
| KRGEITIQEGWEGVK | 176 | Q96DA2 | |
| GLGIWTKRKIEVGEK | 91 | Q03112 | |
| ARTVGGGQKVRWLKK | 81 | O60568 | |
| LVLKRLGFKGVWKGL | 301 | Q00325 | |
| KEELVGGKKKGRTWG | 546 | Q02779 | |
| IWLVDSKGLIVKGRA | 331 | P48163 | |
| GKGLEWVGRIKSKTD | 61 | A0A0B4J1V0 | |
| WKKEEDKKRGGGTAV | 201 | P52945 | |
| KIIKTDGKGWGLVAK | 1066 | O96028 | |
| IVDVGGQKSERKKWI | 206 | P30679 | |
| WGVVADRFKKGKIVL | 121 | Q6ZSS7 | |
| EVVLGNIIKKKGWRR | 96 | Q13303 | |
| GKIWIDKILTTEIGL | 1096 | O15439 | |
| VGQWKERGIGDIKIL | 1371 | A6NKT7 | |
| LTGKGVREGIEWMVK | 171 | Q13795 | |
| IWLSGLLGIKVKAEK | 56 | Q86XJ1 | |
| KAGKEPGLQIWRVEK | 61 | P06396 | |
| CRVVKGKLVEVGKWP | 41 | E5RG02 | |
| KGDIVIIHEKKEGGW | 461 | Q8IVI9 | |
| EIVEVEKGCRKGWKK | 496 | P22897 | |
| VGQWKERGIGDIKIL | 1371 | Q7Z3J3 | |
| AGISGERIWVELKKI | 231 | Q96Q11 | |
| KDVGQWKERGIGDIK | 1361 | P0DJD1 | |
| KRILGRKTKWGTIEV | 511 | Q9UHD8 | |
| KGKGLEGWEKRLIIS | 116 | P30520 | |
| KWEGKNETGLLEKGL | 1971 | Q9P2P6 | |
| TGGGIVRVKELDWLK | 256 | Q9BUU2 | |
| VGLGTWRSLLGKVKE | 16 | C9JRZ8 | |
| EKGGLVEVINKKLWR | 281 | Q99856 | |
| VGRGLVTLDGSKWKK | 121 | Q86W10 | |
| GIEKGGWQTTILGKL | 506 | Q8N2C7 | |
| VDVGDKVWVKLIGRE | 61 | Q9NP64 | |
| IVKRLLGWKKGEQNG | 11 | P84022 | |
| SGVIRSVKKDGEWKV | 16 | Q15833 | |
| LVKERWKVLRKIGGG | 16 | Q6IQ55 | |
| DVEVILTEKKGWGLR | 1551 | Q9BYW2 | |
| ARGGAWGKELILKIV | 1041 | Q96JG9 | |
| WRLGVIKGTASRKGK | 361 | Q86XT4 |